We are live on ! Find out more
GOSS icon

Gossamer Bio
GOSS

100 hedge funds and large institutions have $173M invested in Gossamer Bio in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 31 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 10

36% more call options, than puts

Call options by funds: $785K | Put options by funds: $579K

6% more funds holding

Funds holding: 94 → 100 (+6)

5% more capital invested

Capital invested by funds: $165M → $173M (+$7.91M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3.53% less ownership

Funds ownership: 80.83% → 77.3% (-3.5%)

19% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 31

Holders
100
Holders Change
+6
Holders Change %
+6.38%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
16
Increased
25
Reduced
31
Closed
10
Calls
$785K
Puts
$579K
Net Calls
+$206K
Net Calls Change
+$191K

Top Buyers

Rank Fund Capital Flow
1
MAM
Monaco Asset Management
Monaco
+$1.08M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$904K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$426K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$342K
5
Two Sigma Investments
Two Sigma Investments
New York
+$309K

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$12M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.94M
3
Millennium Management
Millennium Management
New York
-$2.37M
4
Deutsche Bank
Deutsche Bank
Germany
-$1.63M
5
Goldman Sachs
Goldman Sachs
New York
-$1.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$2.09M -$1.63M -1,694,916 -45%
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$1.86M +$426K +442,895 +31%
Renaissance Technologies
28
Renaissance Technologies
New York
$1.72M -$290K -301,795 -15%
LCM
29
Laurion Capital Management
New York
$1.47M -$939K -975,665 -40%
DCM
30
DAFNA Capital Management
California
$1.4M +$9.62K +10,000 +0.7%
Charles Schwab
31
Charles Schwab
California
$1.21M -$32.2K -33,520 -3%
Citadel Advisors
32
Citadel Advisors
Florida
$1.03M -$2.94M -3,053,783 -75%
TD Asset Management
33
TD Asset Management
Ontario, Canada
$880K +$264K +274,752 +43%
MIM
34
Monashee Investment Management
Massachusetts
$848K – – –
Two Sigma Advisers
35
Two Sigma Advisers
New York
$789K -$23K -23,900 -3%
WP
36
Woodline Partners
California
$777K +$5.3K +5,510 +0.7%
Goldman Sachs
37
Goldman Sachs
New York
$721K -$1.33M -1,386,960 -65%
State Street
38
State Street
Massachusetts
$703K – – –
NCM
39
Nantahala Capital Management
Connecticut
$664K – – –
Citigroup
40
Citigroup
New York
$649K +$152K +157,835 +32%
Two Sigma Investments
41
Two Sigma Investments
New York
$622K +$309K +320,982 +104%
HCM
42
Highbridge Capital Management
New York
$590K – – –
BCM
43
Bridgeway Capital Management
Texas
$544K – – –
EAM
44
Exome Asset Management
New York
$462K -$634K -659,200 -58%
ACM
45
ADAR1 Capital Management
Texas
$411K -$111K -115,670 -22%
Northern Trust
46
Northern Trust
Illinois
$405K -$29.2K -30,315 -7%
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$380K +$72.1K +74,920 +24%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$346K +$16.7K +17,367 +5%
DC
49
Diametric Capital
Massachusetts
$283K +$276K +287,259 New
Victory Capital Management
50
Victory Capital Management
Texas
$271K -$6.2K -6,446 -2%
1
2
3 4 5

GOSS Hedge Fund Activity: Q3 2024 in Review

100 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q3 2024, worth a combined $173M — up 4.8% from $165M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new GOSS positions and 10 closed out — a net gain of 6 holders — while 25 added to existing stakes and 31 trimmed.

The largest buyer was Monaco Asset Management, adding an estimated $1.08M. The largest seller was Artal Group, exiting entirely with an estimated $12M sold.

  • 100 institutional investors held Gossamer Bio (GOSS) as of Q3 2024, up from 94 in Q2 2024.
  • Funds reported $173M of Gossamer Bio stock for Q3 2024, up 4.8% quarter-over-quarter.
  • 16 funds opened new Gossamer Bio positions in Q3 2024 and 10 closed out, a net change of +6 holders.
  • The largest Gossamer Bio buyer in Q3 2024 was Monaco Asset Management, an estimated $1.08M added.
  • The largest Gossamer Bio seller in Q3 2024 was Artal Group, an estimated $12M sold.

Based on aggregated 13F filings for Q3 2024.